American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$280M |
| 2 |
Kenvue
KVUE
|
+$272M |
| 3 |
Norfolk Southern
NSC
|
+$240M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
| 5 |
Amazon
AMZN
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$251M |
| 2 |
Walt Disney
DIS
|
+$204M |
| 3 |
Advanced Micro Devices
AMD
|
+$174M |
| 4 |
MarketAxess Holdings
MKTX
|
+$168M |
| 5 |
Johnson & Johnson
JNJ
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
2651
AMTD IDEA Group
AMTD
$70.2M
| $97.5K | ﹤0.01% |
26,417
| – | – |
|
|
FRGE
2652
DELISTED
Forge Global Holdings
FRGE
| $97K | ﹤0.01% |
+3,186
| New | +$117K |
|
2653
Monte Rosa Therapeutics
GLUE
$1.37B
| $94.9K | ﹤0.01% |
19,814
+6,879
| +53% | +$44.3K |
|
|
SRTA
2654
Strata Critical Medical Inc
SRTA
$525M
| $94.5K | ﹤0.01% |
36,499
+24,968
| +217% | +$87.7K |
|
2655
MannKind Corp
MNKD
$1.19B
| $93.4K | ﹤0.01% |
22,609
| – | – |
|
|
OLPX
2656
DELISTED
Olaplex Holdings
OLPX
| $92.5K | ﹤0.01% |
47,448
+17,521
| +59% | +$52.7K |
|
2657
Tenaya Therapeutics
TNYA
$169M
| $91.8K | ﹤0.01% |
35,994
+15,117
| +72% | +$63.3K |
|
|
KC
2658
Kingsoft Cloud Holdings
KC
$3.41B
| $91.7K | ﹤0.01% |
18,592
-49,049
| -73% | -$278K |
|
2659
SelectQuote
SLQT
$129M
| $91K | ﹤0.01% |
77,817
+31,480
| +68% | +$47.5K |
|
|
ORGN
2660
DELISTED
Origin Materials
ORGN
| $88.6K | ﹤0.01% |
2,306
+554
| +32% | +$43.5K |
|
2661
Immuneering
IMRX
$337M
| $87.9K | ﹤0.01% |
+11,450
| New | +$105K |
|
2662
908 Devices
MASS
$417M
| $86.6K | ﹤0.01% |
+13,007
| New | +$90.1K |
|
2663
CS Disco
LAW
$283M
| $86.2K | ﹤0.01% |
+12,984
| New | +$113K |
|
2664
Ranpak Holdings
PACK
$477M
| $85.5K | ﹤0.01% |
15,721
+5,099
| +48% | +$28K |
|
2665
Zevra Therapeutics
ZVRA
$669M
| $85.2K | ﹤0.01% |
17,679
+4,199
| +31% | +$21K |
|
2666
Ponce Financial Group
PDLB
$504M
| $81.6K | ﹤0.01% |
+10,438
| New | +$89.5K |
|
2667
Broadwind
BWEN
$128M
| $81.1K | ﹤0.01% |
25,341
-1,298
| -5% | -$4.94K |
|
2668
Hippo Holdings
HIPO
$872M
| $80.8K | ﹤0.01% |
+10,141
| New | +$128K |
|
2669
Custom Truck One Source
CTOS
$2.42B
| $80.7K | ﹤0.01% |
13,013
+2,103
| +19% | +$13.9K |
|
2670
Erasca
ERAS
$6.38B
| $79.6K | ﹤0.01% |
40,410
+11,304
| +39% | +$29K |
|
2671
Fate Therapeutics
FATE
$310M
| $78.6K | ﹤0.01% |
37,062
+15,848
| +75% | +$52.5K |
|
2672
Seer Inc
SEER
$116M
| $78.5K | ﹤0.01% |
35,522
+9,456
| +36% | +$32.8K |
|
|
SKYT
2673
DELISTED
SkyWater Technology
SKYT
| $78.4K | ﹤0.01% |
+13,019
| New | +$98.8K |
|
2674
Leslie's
LESL
$7.04M
| $76.9K | ﹤0.01% |
679
+4
| +0.6% | +$524 |
|
|
INZY
2675
DELISTED
Inozyme Pharma
INZY
| $75.9K | ﹤0.01% |
18,073
+5,873
| +48% | +$29.9K |
|
Similar funds
American Century Companies's Q3 2023 Portfolio in Review
As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
- American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
- American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
- American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
- American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
- American Century Companies opened 141 new positions and closed 91 in Q3 2023.
- American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.